Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

AstraZeneca
Federal Trade Commission
Farmers Insurance
Express Scripts
Deloitte
Fish and Richardson
McKinsey
Boehringer Ingelheim
Accenture
Merck

Generated: August 22, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 019763

« Back to Dashboard
NDA 019763 describes IFEX/MESNEX KIT, which is a drug marketed by Baxter Hlthcare and is included in one NDA. It is available from one supplier. Additional details are available on the IFEX/MESNEX KIT profile page.

The generic ingredient in IFEX/MESNEX KIT is ifosfamide; mesna. There are five drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the ifosfamide; mesna profile page.

Summary for NDA: 019763

Tradename:
2
Applicant:
1
Ingredient:
2
Patents:0
Formulation / Manufacturing:see details

Pharmacology for NDA: 019763

Mechanism of ActionAlkylating Activity

Suppliers and Packaging for NDA: 019763

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
IFEX
ifosfamide
INJECTABLE;INJECTION 019763 NDA Baxter Healthcare Corporation 0338-3991 0338-3991-01 1 VIAL, SINGLE-DOSE in 1 CARTON (0338-3991-01) > 20 mL in 1 VIAL, SINGLE-DOSE
IFEX
ifosfamide
INJECTABLE;INJECTION 019763 NDA Baxter Healthcare Corporation 0338-3993 0338-3993-01 1 VIAL, SINGLE-DOSE in 1 CARTON (0338-3993-01) > 60 mL in 1 VIAL, SINGLE-DOSE

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength1GM/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
Approval Date:Dec 30, 1988TE:APRLD:Yes

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength3GM/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
Approval Date:Dec 30, 1988TE:APRLD:Yes

Summary for product number 003

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;INJECTIONStrength1GM/VIAL;100MG/ML
Approval Date:Oct 10, 1992TE:RLD:No

Expired Orange Book Patents for NDA: 019763

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Baxter Hlthcare
IFEX/MESNEX KIT
ifosfamide; mesna
INJECTABLE;INJECTION019763-004Oct 10, 1992► Subscribe► Subscribe
Baxter Hlthcare
IFEX/MESNEX KIT
ifosfamide; mesna
INJECTABLE;INJECTION019763-004Oct 10, 1992► Subscribe► Subscribe
Baxter Hlthcare
IFEX
ifosfamide
INJECTABLE;INJECTION019763-001Dec 30, 1988► Subscribe► Subscribe
Baxter Hlthcare
IFEX/MESNEX KIT
ifosfamide; mesna
INJECTABLE;INJECTION019763-004Oct 10, 1992► Subscribe► Subscribe
Baxter Hlthcare
IFEX/MESNEX KIT
ifosfamide; mesna
INJECTABLE;INJECTION019763-003Oct 10, 1992► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.



Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Farmers Insurance
McKinsey
Merck
QuintilesIMS
Fuji
McKesson
Cerilliant
Covington
UBS
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot